|
|
||||||||
Ogawa K, Ono K, Kurohmaru M, Hayashi Y. Effect of streptozotocin injection on expression of immunoreactive follistatin and βA and βB subunits of inhibin/activin in rat pancreatic islets. Eur J Endocrinol 1995;132:363–9. ISSN 0804–4643
The effect of streptozotocin (STZ) on expression of immunoreactive follistatin and β-subunits of inhibin/activin in pancreatic islets was studied by immunohistochemistry. To localize immunoreactive follistatin in pancreatic islets, two different anti-follistatin sera were used. Anti-follistatin(300–315) serum detects only long-form follistatin, while anti-follistatin(123–134) serum detects both long- and C-terminal truncated short-form follistatin in sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunoblotting. Although an intense reaction with anti-follistatin(123–134) was found in pancreatic B cells, a reaction with anti-follistatin(300–315) was not present in any type of cells. This result suggests that only short-form follistatin is expressed in pancreatic islets. It was confirmed that immunoreaction with anti-βA(1–10)-Tyr serum was found in pancreatic B cells. The anti-βB(1–10)-Tyr reaction was intense in A cells but weak in B cells. These findings suggest that the expression pattern of each β-subunit differs in each type of islet cells. At 2 weeks after STZ injection (65 mg/kg), insulin immunoreaction still remained in B cells, although most pancreatic B cells were destroyed. In contrast, immunoreactions of follistatin and β-subunits in B cells disappeared 24 h after STZ treatment. These results indicate that STZ affects the production of follistatin or β-subunits of inhibin/activin in pancreatic B cells rather than insulin secretion.
Kenji Ogawa, Department of Veterinary Anatomy, Faculty of Agriculture, The University of Tokyo, Bunkyo-ku, Tokyo 113, Japan
This article has been cited by other articles:
![]() |
S. La Rosa, S. Uccella, S. Marchet, C. Capella, and R. V. Lloyd Localization of Inhibins and Activins in Normal Endocrine Cells and Endocrine Tumors of the Gut and Pancreas: an Immunohistochemical and In Situ Hybridization Study J. Histochem. Cytochem., February 1, 2004; 52(2): 217 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morioka, H. Koyama, H. Yamamura, S. Tanaka, S. Fukumoto, M. Emoto, H. Mizuguchi, T. Hayakawa, I. Kojima, K. Takahashi, et al. Role of H1-Calponin in Pancreatic AR42J Cell Differentiation Into Insulin-Producing Cells Diabetes, March 1, 2003; 52(3): 760 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Q. Zhang, H. Zhang, A. Maeshima, H. Kurihara, J.-i. Miyagawa, T. Takeuchi, and I. Kojima Up-Regulation of the Expression of Activins in the Pancreatic Duct by Reduction of the {beta}-Cell Mass Endocrinology, September 1, 2002; 143(9): 3540 - 3547. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Demeterco, G. M. Beattie, S. A. Dib, A. D. Lopez, and A. Hayek A Role for Activin A and Betacellulin in Human Fetal Pancreatic Cell Differentiation and Growth J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3892 - 3897. [Abstract] [Full Text] |
||||
![]() |
D. J. Hecht, A. J. Davis, C. F. Brooks, and P. A. Johnson Molecular Cloning and Expression Analysis of the Complementary Deoxyribonucleic Acid for Chicken Inhibin/Activin {beta}B Subunit Biol Reprod, May 1, 2000; 62(5): 1128 - 1134. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |